Mecamylamine
Back to searchMolecule Structure
Scientific Name
Mecamylamine
Description of the Drug
Mecamylamine is a nicotine antagonist used to treat moderate to severe essential hypertension and uncomplicated malignant hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00657
http://www.drugbank.ca/drugs/DB00657
Brand Name(s)
Not Available
Company Owner(s)
Lgm Pharma Solutions Llc, Targacept Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Neuronal acetylcholine receptor; alpha3/beta4 | PROTEIN COMPLEX | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL1907594 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34252 | |
| PharmGKB | PA450334 | |
| Human Metabolome Database | HMDB0014795 | |
| DrugBank | DB00657 | |
| PubChem: Thomson Pharma | 14748127 | |
| PubChem | 4032 | |
| NMRShiftDB | 70008387 | |
| LINCS | LSM-4990 | |
| Nikkaji | J4.802J | |
| BindingDB | 50061565 | |
| EPA CompTox Dashboard | DTXSID0023240 | |
| DrugCentral | 1646 | |
| Brenda | 147739 | |
| Guide to Pharmacology | 3990 | |
| rxnorm | MECAMYLAMINE | MECAMYLAMINE HYDROCHLORIDE |
| KEGG Ligand | C07511 | |
| ChEBI | 6706 |
